IVIG Therapy May Be Effective, Safe for COVID-19 in Cushing’s Patients
A 70-year-old woman with ectopic Cushing’s syndrome was successfully treated for COVID-19 with intravenous immunoglobulins (IVIg) — a therapy prepared from the blood of thousands of healthy donors that contains a mixture of antibodies — according to a case report. Given the lack of guidelines for the management of…